Acrylonitrile → HCID 67374206, 화합물

HRID 2168632노트

반응식

HRID 2168632 반응식
Cl.Cl.[CH2:3]([C:7]1[N:8]=[N:9][C:10]([O:26][CH:27]2[CH2:32][CH2:31][N:30]([CH3:33])[CH2:29][CH2:28]2)=[CH:11][C:12]=1[C:13]1[CH:18]=[CH:17][C:16]([O:19][CH:20]2[CH2:25][CH2:24][CH2:23][CH2:22][CH2:21]2)=[CH:15][CH:14]=1)[CH2:4][CH2:5][CH3:6].[C:34](#[N:37])[CH:35]=C>>[CH2:3]([C:7]1[N:8]=[N:9][C:10]([O:26][CH:27]2[CH2:32][CH2:31][N:30]([CH2:33][CH2:35][C:34]#[N:37])[CH2:29][CH2:28]2)=[CH:11][C:12]=1[C:13]1[CH:14]=[CH:15][C:16]([O:19][CH:20]2[CH2:25][CH2:24][CH2:23][CH2:22][CH2:21]2)=[CH:17][CH:18]=1)[CH2:4][CH2:5][CH3:6]

참가 물질

3

반응물 2

HCID 7855AcrylonitrileHCID 53373967HCID 53373967, 화합물

생성물 1

HCID 67374206HCID 67374206, 화합물

실험 절차

A mixture of 3-butyl-4-(4-cyclohexyloxy-phenyl)-6-(piperidin-4-yloxy)-pyridazine (Example 14, 0.244 mmol, 100 mg) and acrylonitrile (1 mL) may be stirred at room temperature for 20 h. The organic solvent may be removed in vacuo, and the residue may be purified by column chromatography on silica gel using 1-2% of MeOH in DCM to provide 3-{4-[6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazin-3-yloxy]-piperidin-1-yl}-propionitrile.

후처리

  1. customThe organic solvent may be removed in vacuo
  2. customthe residue may be purified by column chromatography on silica gel using 1-2% of MeOH in DCM

출처 및 근거

ORD 기록
ord-b73889c3e2e14f67bce85eace998d908
출처 데이터셋
uspto-grants-2015_06
특허 번호
US09045461B2

반응 노트

불러오는 중…